Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared.-Reference-Cited by-同舟云学术

Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared.

Published:1975-11-01 Issue:11 Volume:16 Page:876-883
ISSN:0017-5749
Container-title:Gut
language:en
Short-container-title:Gut

Author:

Summerskill W H,Korman M G,Ammon H V,Baggenstoss A H

Publisher

BMJ

Subject

Gastroenterology

Reference23 articles.

1. Characterization and incidence of remission and relapse in chronic active liver disease (CALD);Ammon, H.V.; Baggenstoss, A.H.; Summerskill, W.H.J.;(Abstract). Gastroenterology,1972

2. Initial morphologic appearances determine responses to treatment of chronic active liver disease (CALD); a prospective study;Ammon, H.V.; Summerskill, W.H.J.; Baggenstoss, A.H.;(Abstract). Gas-troenterology,1973

3. Chronic active liver disease. The range of histologic lesions, their responses to treatment, and their evolution;Baggenstoss, A.H.; Soloway, R.D.; Summerskill, W.H.J.;Human Pathology,1972

4. Prognosis of chronic persistent hepatitis;Becker, M.D.; Scheur, P.J.; Baptista, A.; Sherlock, S.;Lancet,1970

5. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis;Cook, C.G.; Mulligan, R.; Sherlock, S.;Quarterly Journal of Medicine,1971

Cited by 317 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic safety and efficacy of immunomodulatory drugs used in patients with autoimmune hepatitis;Journal of Autoimmunity;2023-11

2. KASL clinical practice guidelines for management of autoimmune hepatitis 2022;Clinical and Molecular Hepatology;2023-07-01

3. Clinical trials reimagined;Hepatology;2023-05-05

4. Treatment of Autoimmune Hepatitis;The Korean Journal of Gastroenterology;2023-02-25

5. Open challenges in the management of autoimmune hepatitis;Minerva Gastroenterology;2023-02